These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25194444)

  • 21. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
    Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
    Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
    Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
    J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. POT1 as a terminal transducer of TRF1 telomere length control.
    Loayza D; De Lange T
    Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.
    Lei M; Podell ER; Cech TR
    Nat Struct Mol Biol; 2004 Dec; 11(12):1223-9. PubMed ID: 15558049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
    Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
    Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of telomere length by the human telomeric protein TRF1.
    van Steensel B; de Lange T
    Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.
    Bunch JT; Bae NS; Leonardi J; Baumann P
    Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
    Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.
    Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W
    Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spatiotemporal expression of TERT and telomere repeat binding proteins in the postnatal mouse testes.
    Kosebent EG; Ozturk S
    Andrologia; 2021 Apr; 53(3):e13976. PubMed ID: 33544428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTOP interacts with POT1 and regulates its localization to telomeres.
    Liu D; Safari A; O'Connor MS; Chan DW; Laegeler A; Qin J; Songyang Z
    Nat Cell Biol; 2004 Jul; 6(7):673-80. PubMed ID: 15181449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against chromosome degradation at the telomeres.
    Grandin N; Charbonneau M
    Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of telomerase by telomeric proteins.
    Smogorzewska A; de Lange T
    Annu Rev Biochem; 2004; 73():177-208. PubMed ID: 15189140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
    Bitisik O; Yavuz S; Yasasever V; Dalay N
    Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
    Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
    Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
    Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
    Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.